CRYSTAL RANDALL: Open Payments
NPI 1598262453 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 10 payments from 5 companies in 2025. Trend: 2023 $456 · 2024 $587 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $108 |
| Exact Sciences Corporation | 5 | $108 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Novo Nordisk Inc | 2 | $34 |
| PFIZER INC. | 1 | $18 |
Products named: AIRSUPRA, The Cologuard Plus Collection Kit, SHINGRIX, PREVNAR 20, Rybelsus, Ozempic.
Industry payments across MD — which companies pay providers there.
